Cargando…

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome

Fatty liver syndrome is an emerging health problem in the world, due to the high prevalence of obesity and alcohol use disorder. Given the nature of the disease’s advancement to cirrhosis and liver-related complications, it is important to assess the severity of the disease, which is typically done...

Descripción completa

Detalles Bibliográficos
Autor principal: Han, Ma Ai Thanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555355/
https://www.ncbi.nlm.nih.gov/pubmed/32933184
http://dx.doi.org/10.3390/life10090198
_version_ 1783593988628938752
author Han, Ma Ai Thanda
author_facet Han, Ma Ai Thanda
author_sort Han, Ma Ai Thanda
collection PubMed
description Fatty liver syndrome is an emerging health problem in the world, due to the high prevalence of obesity and alcohol use disorder. Given the nature of the disease’s advancement to cirrhosis and liver-related complications, it is important to assess the severity of the disease, which is typically done via a liver biopsy. Due to the limitations and risks of liver biopsy, the role of noninvasive tests is essential and evolving to stratify the stage of the liver disease, predict the outcomes, and/or monitor the treatment response. This review is focused on noninvasive tests, including the use of serum-based biomarkers, ultrasound-based shear wave elastography, transient elastography, and magnetic resonance elastography in both clinical and research settings.
format Online
Article
Text
id pubmed-7555355
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75553552020-10-19 Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome Han, Ma Ai Thanda Life (Basel) Review Fatty liver syndrome is an emerging health problem in the world, due to the high prevalence of obesity and alcohol use disorder. Given the nature of the disease’s advancement to cirrhosis and liver-related complications, it is important to assess the severity of the disease, which is typically done via a liver biopsy. Due to the limitations and risks of liver biopsy, the role of noninvasive tests is essential and evolving to stratify the stage of the liver disease, predict the outcomes, and/or monitor the treatment response. This review is focused on noninvasive tests, including the use of serum-based biomarkers, ultrasound-based shear wave elastography, transient elastography, and magnetic resonance elastography in both clinical and research settings. MDPI 2020-09-13 /pmc/articles/PMC7555355/ /pubmed/32933184 http://dx.doi.org/10.3390/life10090198 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Han, Ma Ai Thanda
Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title_full Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title_fullStr Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title_full_unstemmed Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title_short Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome
title_sort noninvasive tests (nits) for hepatic fibrosis in fatty liver syndrome
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555355/
https://www.ncbi.nlm.nih.gov/pubmed/32933184
http://dx.doi.org/10.3390/life10090198
work_keys_str_mv AT hanmaaithanda noninvasivetestsnitsforhepaticfibrosisinfattyliversyndrome